Erratum
for
Mouridsen et al., J Clin Oncol 19 (10) 2596-2606.
Journal of Clinical Oncology, Vol 19, Issue 13
(July), 2001: 3302
© 2001 American Society for Clinical Oncology
ERRATUM
In the Rapid Publication by Mouridsen et al that appeared in the May 15, 2001, issue entitled "Superior Efficacy of Letrozole Versus Tamoxifen as First-Line Therapy for Postmenopausal Women With Advanced Breast Cancer: Results of a Phase III Study of the International Letrozole Breast Cancer Group" (J Clin Oncol 19:2596-2606, 2001), the locations for the independent consultant and Novartis Pharma AG given in the footnote section were incorrect. The correct locations are as follows: "Independent Consultant, Milan, Italy; Novartis Pharma AG, Basel, Switzerland." The publisher regrets this error.

CiteULike Complore Connotea Del.icio.us Digg Facebook Reddit Technorati Twitter What's this?
This article has been cited by other articles:

|
 |

|
 |
 
P. Bruzzi
Non-drug industry funded research
BMJ,
January 5, 2008;
336(7634):
1 - 2.
[Full Text]
[PDF]
|
 |
|
|